An EPIC Based BPA to Enhance Quit Line Referral and Use



Status:Enrolling by invitation
Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:2/6/2019
Start Date:April 18, 2017
End Date:May 30, 2019

Use our guide to learn which trials are right for you!

Smoking is the number one cause of preventable death in the United States. Given the
magnitude of the problem, interventions aimed at promoting smoking cessation have the
potential to make large changes in improving health outcomes. Resources to aid with smoking
cessation such as telephone-based counseling are generally underutilized. The electronic
medical record (EMR) in use at Johns Hopkins has limited decision support to promote referral
to the Maryland Quit Line, a free smoking cessation counseling resource. The investigators
propose a cluster randomized trial (Implementation-RCT hybrid design) with a waitlist control
at the 22 Johns Hopkins Community Physicians (JHCP) sites, which offer primary care. The
intervention will include a multi-modality intervention to promote provider use of smoking
cessation resources which include an Epic-based Best Practice Advisory (BPA) that allows
providers to electronically refer to the Maryland State Quit Line, educational materials, and
provider visits with Quit Line representatives to review use of smoking cessation practices.
Sites will be randomized to one of three arms with increasing support: 1) six-month waitlist
control; 2) BPA with optional educational modules; 3) BPA with online educational modules, a
quick-reference educational document, and additional visit with Quit Line representatives.
The investigators hypothesize that by implementing a new Epic BPA that allows providers to
easily refer to the Maryland Quit Line electronically, investigators will increase use of
this resource. The investigators also hypothesize that adding additional educational
materials and having Quit Line representatives perform educational outreach visits will
further increase use of the Quit Line and will increase prescription of medications to assist
with smoking cessation. Ultimately The investigators hope to improve patient care by
increasing providers' use the Maryland Quit Line and pharmacotherapy. The investigators hope
that the use of these resources will decrease smoking rates and thereby improve patient
health and outcomes while improving JHCP quality metrics.

Smoking is the number one cause of preventable death in the United States. Given the
magnitude of the problem, interventions aimed at promoting smoking cessation have the
potential to make large changes in improving health outcomes. Resources to aid with smoking
cessation such as telephone-based counseling are generally underutilized. The electronic
medical record (EMR) in use at Johns Hopkins has limited decision support to promote referral
to the Maryland Quit Line, a free smoking cessation counseling resource. The investigators
propose a cluster randomized trial (Implementation-RCT hybrid design) with a waitlist control
at the 22 Johns Hopkins Community Physicians (JHCP) sites, which offer primary care. The
intervention will include a multi-modality intervention to promote provider use of smoking
cessation resources which include an Epic-based Best Practice Advisory (BPA) that allows
providers to electronically refer to the Maryland State Quit Line, educational materials, and
provider visits with Quit Line representatives to review use of smoking cessation practices.
Sites will be randomized to one of three arms with increasing support: 1) six-month waitlist
control; 2) BPA with optional educational modules; 3) BPA with online educational modules, a
quick-reference educational document, and additional visit with Quit Line representatives.
The investigators hypothesize that by implementing a new Epic BPA that allows providers to
easily refer to the Maryland Quit Line electronically, The investigators will increase use of
this resource. The investigators also hypothesize that adding additional educational
materials and having Quit Line representatives perform educational outreach visits will
further increase use of the Quit Line and will increase prescription of medications to assist
with smoking cessation. Ultimately, the investigators hope to improve patient care by
increasing providers' use the Maryland Quit Line and pharmacotherapy. The investigators hope
that the use of these resources will decrease smoking rates and thereby improve patient
health and outcomes while improving JHCP quality metrics.

The primary goal of this study is to test the effectiveness of instituting an Epic BPA in
increasing Maryland Quit Line referrals. The secondary goals are to measure the BPA's effect
and the effect of additional provider education on patient engagement with the Quit Line, and
on prescription of medications that aid in smoking cessation.

Aim 1: In a three-arm, cluster randomized trial, to test the effectiveness of an Epic BPA
with provider educational support and provider detailing in provision of smoking cessation
services.

Hypothesis 1: An Epic-based BPA to prompt providers to electronically refer people who are
ready to quit smoking to the Maryland Quit Line will increase use of this service compared to
waitlist control.

Hypothesis 2: An Epic-based BPA supplemented with educational materials and academic
detailing will increase Quit-Line referral compared to control.

Hypothesis 3: Additional provider support including educational materials, in-person academic
detailing, will increase successful referrals to the Quit Line and prescription of cessation
pharmacotherapy compared to waitlist control and BPA only

Inclusion Criteria:

- Johns Hopkins Community Physicians Primary Care Practices (Internal Medicine and
Family Medicine)

Exclusion Criteria:
We found this trial at
1
site
2700 Remington Avenue
Baltimore, Maryland 21211
?
mi
from
Baltimore, MD
Click here to add this to my saved trials